SpaceM is proud to introduce two pioneering methods built on Bruker mass spectrometry technology, HT SpaceM and 13C-SpaceM, that are set to transform drug discovery and precision medicine.
These approaches provide deeper insights into cellular functions, metabolic pathways, and drug toxicity, addressing challenges that bulk methods miss. Join us in pushing the boundaries of single-cell analysis and exploring how these innovations can enhance your research and development efforts.
Due to illness of speaker this webinar need to be cancelled and will be postponed to 2025
Shawn Owens, Ph.D., Imaging Mass Spectrometrist, SpaceM, BioInnovation Institute, Copenhagen, Denmark
For Research Use Only. Not for use in clinical diagnostic procedures.